## Background: Onycholysis has been reported in association with the use of several noncytotoxic drugs and with chemotherapy in 135 patients. onycholysis may be precipitated by exposure to ultraviolet radiation. ## Methods: The authors studied 91 patients who received paclitaxel and 187 patients
Onycholysis and subungual haemorrhages secondary to systemic chemotherapy (paclitaxel)
✍ Scribed by E Ghetti; BM Piraccini; A Tosti
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 58 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0926-9959
No coin nor oath required. For personal study only.
✦ Synopsis
ABSTRACT
Paclitaxel is a chemotherapic agent of the taxane family used in treatment of malignant solid tumory. We report here the case of a 40‐year old woman referred to our clinic for nail changes involving all 20 digits and developed after 5 months of paclitaxel intake, due to a breast carcinoma.
Clinical examination revealed red‐brown discoloration of the nails associated with hematomas and onycholysis. The nail changes were very painful and the patient complained of discharge of bad‐smelling yellow brown opaque fluid from underneath the nail plate.
Hemorrhagic onycholysis and subungual abscesses are a possible side effect of taxane treatment that should be early recognized to prevent serious complications.
📜 SIMILAR VOLUMES